SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Russian Bear who wrote (26620)11/18/1998 6:13:00 PM
From: Cheryl Galt  Read Replies (1) of 32384
 
RB, Thanks for relaying Peter's explanation of how the FDA "moved the goalposts."
I'm wondering how long ago the goalposts were moved.

But mostly, I'm dumbfounded at how ILLOGICAL it is to judge healing based on photographs -- especially if efficacy is based on the COLOR of the healed tissue. Besides moving the goalposts, the FDA seems also to have instituted a wrong-headed criterion -- in my humble opinion.

Anybody who commutes by bike knows how LONG a healed scrape -- now intact and painless -- retains a distinct pink color and shine. Easily weeks.
(I'll have to keep a log for a while, to check this out, but I'm quite sure it's true.)

I'm not kidding. I'm serious. To look at a colored photo and decide something isn't nicely healed just because it's still pink -- that's foolish. For a patient to object that healing has a pink stage, that's irrelevant. When a sign of good healing is evaluated as inefficacy, I expect that there is a good case for discussion and re-evaluation. It's time to submit some authoritative, well-written position statements.

My comments aren't scientific, but common sense experience and logic ought to be worth something. I hope those goalposts aren't cast in too much concrete.
What's been moved can be shifted again, in a logical direction.

My .01
Cheryl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext